These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
20 related articles for article (PubMed ID: 5326485)
1. Ponalid in the treatment of non-chemical parkinsonism: a souble-blind study with nine months' follow-up. Strang RR Med J Aust; 1965 Aug; 2(9):360-1. PubMed ID: 5318245 [No Abstract] [Full Text] [Related]
2. Clinical evaluation of biperiden in Parkinson's disease. Strang RR Dis Nerv Syst; 1967 Mar; 28(3):191-3. PubMed ID: 5335879 [No Abstract] [Full Text] [Related]
3. [Comparative neurophysiologic studies on tremor-inhibiting substances]. Ganglberger JA; Umbach W Med Klin; 1965 Aug; 60(32):1283-8. PubMed ID: 4378886 [No Abstract] [Full Text] [Related]
4. A double-blind evaluation of S.D. 25 in the treatment of Parkinson's disease. Strang RR Curr Med Drugs; 1966 Dec; 7(4):20-6. PubMed ID: 5976205 [No Abstract] [Full Text] [Related]
5. Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease. Silver DE; Sahs AL Trans Am Neurol Assoc; 1971; 96():307-8. PubMed ID: 4945919 [No Abstract] [Full Text] [Related]
6. [Which drug to use for the initiation of treatment for early Parkinson's disease]. Marttila R Duodecim; 2004; 120(5):587-90. PubMed ID: 15060995 [No Abstract] [Full Text] [Related]
7. A double-blind evaluation of lysivane in the treatment of Parkinson's disease. Strang RR Br J Clin Pract; 1966 May; 20(5):249-51. PubMed ID: 5326485 [No Abstract] [Full Text] [Related]